Publications

5808 Results

Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033 [PMID18235122]

Authors
CD Blanke;C Rankin;GD Demetri;CW Ryan;M von Mehren;RS Benjamin;AK Raymond;VH Bramwell;LH Baker;RG Maki;JR Hecht;MC Heinrich;CD Fletcher;JJ Crowley;EC Borden
Journal / Conference
Journal of Clinical Oncology 26(4):626-632
Year
2008
Research Committee(s)
Sarcoma
Study Number(s)
S0033

Serum steroid and sex hormone binding globulin concentrations and the risk of incident benign prostatic hyperplasia (BPH): Results from the Prostate Cancer Prevention Trial. PMC2387066; PMID: 18267333.

Authors
AR Kristal;YJ Song;JM Schenk;KB Arnold;Z Gong;ML Neuhouser;P Goodman;C Tangen;DW Lin;F Stanczyk;IM Thompson
Journal / Conference
American Journal of Epidemiology 168(12):1416-1424
Year
2008
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the Prostate Cancer Prevention Trial

Authors
ML Neuhouser;J Schenk;Y Song;CM Tangen;P Goodman;M Pollak;DF Penson;IM Thompson;AR Kristal
Journal / Conference
Prostate 68(13):1477-1486
Year
2008
Research Committee(s)
Cancer Control
PMID
PMID18618736
PMC
PMC2564287
Study Number(s)
SWOG-9217

Integrating the predictiveness of a marker with its performance as a classifier

Authors
MS Pepe;Z Feng;Y Huang;G Longton;R Prentice;IM Thompson;Y Zheng
Journal / Conference
American Journal of Epidemiology 167(3):362-368
Year
2008
Research Committee(s)
Cancer Control
PMID
PMID179821157
PMC
PMC2939738
Study Number(s)
SWOG-9217

Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for post-transplantation lymphoproliferative disorder (PTLD) [PMID: 18645482]

Authors
LJ Swinnen;M LeBlanc;TM Grogan;LI Gordon;PJ Stiff;AM Miller;Y Kasamon;TP Miller;RI Fisher
Journal / Conference
Transplantation 86(2):215-222
Year
2008
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9239

Phase II studies of different schedules and doses of the farnesyltransferase inhibitor tipifarnib (R11577, zarnestra) for patients age 70 or older with previously untreated acute myeloid leukemia (AML): North American Intergroup Study S0432.

Authors
HP Erba;KJ Kopecky;MH Kirschbaum;MS Tallman;RA Larson;CL Willman;ML Slovak;HM Gundacker;FR Appelbaum
Journal / Conference
Annals of Hematology 87(Suppl.1):S57-S59
Year
2008
Research Committee(s)
Leukemia
Study Number(s)
S0432

A Phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149) [PMID18175205]

Authors
LJ Swinnen;C Rankin;H Carraway;KS Albain;JJ Townsend;GT Budd;JA Kish;SE Rivkin;DT Blumenthal
Journal / Conference
Journal of Neurooncology 86:353-358
Year
2008
Research Committee(s)
Brain
Study Number(s)
SWOG-9149

Pelvic failure (PF) analysis in INT0144: evaluation of chemotherapy regimen, risk group stratification, and nodal count

Authors
SR Smalley;C Rankin;J Benedetti;SK Williamson;JM Robertson;R Tyvin;JA Martenson;AB Benson;RJ Mayer;C Cripps
Journal / Conference
International Journal of Radiation Oncology Biology Physics 72:S70
Year
2008
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9304 (INT-0144)

Does finasteride affect the severity of prostate cancer? A causal sensitivity analysis

Authors
BE Shepherd;M Redman;DP Ankerst
Journal / Conference
Journal of the American Statistical Association 103(484):1392-1404
Year
2008
Research Committee(s)
Cancer Control
PMID
PMID20526381
PMC
PMC2880822
Study Number(s)
SWOG-9217

The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation in those patients: data from SWOG 8794 [PMID18930488]

Authors
GP Swanson;B Goldman;CM Tangen;JL Chin;EM Messing;ED Canby-Higino;JD Forman;IM Thompson;ED Crawford
Journal / Conference
Journal of Urology 180:2453-2457
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8794